Use of soybean broad-spectrum disease resistance related gene
US12163144B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2020 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Apr 7, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/8213
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The GmLMM1 gene, which is involved in the regulation of PTI immune responses, Phytophthora resistance, bacterial blight of soybean disease, soybean halo disease, etc., is cloned in soybeans. The PTI immune response and pathogen resistance of plants can be negatively regulated via the GmLMM1 gene. By reducing the expression of GmLMM1, the PTI immune response of plants can be effectively enhanced, and the pathogen resistance of plants can be increased. Cloning and functional discovery of the GmLMM1 gene provide important foundations and theoretical support for research on the related mechanisms of soybean disease resistance and provide valuable genetic resources for advancing the research and application of plant defense systems. Additionally, cloning and functional delivery of the GmLMM1 gene allows for breeding new soybean varieties with high disease resistance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.